JVMAX | VVONX | JVMAX / VVONX | |
Total Expense Ratio | 1.12 | 0.76 | 147% |
Annual Report Gross Expense Ratio | 1.13 | 0.76 | 149% |
Fund Existence | 28 years | 14 years | - |
Gain YTD | -8.576 | -12.265 | 70% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.4B | 4.28B | 454% |
Annual Yield % from dividends | 0.61 | 0.65 | 95% |
Returns for 1 year | -11.80 | -0.81 | 1,459% |
Returns for 3 years | -9.16 | 11.03 | -83% |
Returns for 5 years | 45.43 | 124.52 | 36% |
Returns for 10 years | 18.32 | 35.48 | 52% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 24.36 | 0.35 | +1.46% |
First Trust Nasdaq Pharmaceuticals ETF | |||
PGZ | 10.13 | 0.12 | +1.20% |
PRINCIPAL REAL ESTATE Income FUND | |||
PFM | 43.48 | 0.24 | +0.56% |
Invesco Dividend Achievers™ ETF | |||
ISTB | 48.22 | N/A | +0.01% |
iShares Core 1-5 Year USD Bond ETF | |||
AMZY | 14.47 | -0.45 | -3.02% |
YieldMax AMZN Option Income Strategy ETF |